These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5501 related articles for article (PubMed ID: 3669023)
1. 1,2-Bis(sulfonyl)hydrazines. 3. Effects of structural modification on antineoplastic activity. Shyam K; Hrubiec RT; Furubayashi R; Cosby LA; Sartorelli AC J Med Chem; 1987 Nov; 30(11):2157-61. PubMed ID: 3669023 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of 2-substituted 1-methyl-1-(4-tolylsulfonyl)hydrazines as antineoplastic agents. Hrubiec RT; Shyam K; Cosby LA; Furubayashi R; Sartorelli AC J Med Chem; 1986 Jul; 29(7):1299-301. PubMed ID: 3806580 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of 1-(arylsulfonyl)-2-[(methoxycarbonyl)sulfenyl]-1-methylhydrazines++ + as antineoplastic agents. Hrubiec RT; Shyam K; Cosby LA; Sartorelli AC J Med Chem; 1986 Sep; 29(9):1777-9. PubMed ID: 3746822 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 1-acyl-1,2-bis(methylsulfonyl)-2-(2- chloroethyl)hydrazines as antineoplastic agents. Shyam K; Penketh PG; Divo AA; Loomis RH; Rose WC; Sartorelli AC J Med Chem; 1993 Nov; 36(23):3496-502. PubMed ID: 8246218 [TBL] [Abstract][Full Text] [Related]
5. 1,2-bis(arylsulfonyl)hydrazines. 2. The influence of arylsulfonyl and aralkylsulfonyl substituents on antitumor and alkylating activity. Shyam K; Furubayashi R; Hrubiec RT; Cosby LA; Sartorelli AC J Med Chem; 1986 Jul; 29(7):1323-5. PubMed ID: 3806585 [TBL] [Abstract][Full Text] [Related]
6. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity. Finch RA; Shyam K; Penketh PG; Sartorelli AC Cancer Res; 2001 Apr; 61(7):3033-8. PubMed ID: 11306484 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 1,2,2-tris(sulfonyl)hydrazines as antineoplastic and trypanocidal agents. Shyam K; Penketh PG; Divo AA; Loomis RH; Patton CL; Sartorelli AC J Med Chem; 1990 Aug; 33(8):2259-64. PubMed ID: 2374151 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of N,N'-bis(arylsulfonyl)hydrazines as antineoplastic agents. Shyam K; Cosby LA; Sartorelli AC J Med Chem; 1985 Apr; 28(4):525-7. PubMed ID: 3981547 [TBL] [Abstract][Full Text] [Related]
9. Antitumor 2-(aminocarbonyl)-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)- hydrazines. Shyam K; Penketh PG; Loomis RH; Rose WC; Sartorelli AC J Med Chem; 1996 Feb; 39(3):796-801. PubMed ID: 8576923 [TBL] [Abstract][Full Text] [Related]
10. On a new class of mixed-function drugs associating nitroimidazoles and CENU: the NICE-NU. Carminati A; Barascut JL; Chenut E; Bourut C; Mathé G; Imbach JL Anticancer Drug Des; 1988 Jun; 3(1):57-65. PubMed ID: 3382507 [TBL] [Abstract][Full Text] [Related]
11. Anticancer activity in murine and human tumor cell lines of bis(platinum) complexes incorporating straight-chain aliphatic diamine linker groups. Kraker AJ; Hoeschele JD; Elliott WL; Showalter HD; Sercel AD; Farrell NP J Med Chem; 1992 Nov; 35(24):4526-32. PubMed ID: 1335074 [TBL] [Abstract][Full Text] [Related]
12. N-benzyladriamycin-14-valerate versus progressively doxorubicin-resistant murine tumours: cellular pharmacology and characterisation of cross-resistance in vitro and in vivo. Ganapathi R; Grabowski D; Sweatman TW; Seshadri R; Israel M Br J Cancer; 1989 Dec; 60(6):819-26. PubMed ID: 2605093 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of 2,3-diaziridinyl-1,4-naphthoquinone sulfonate derivatives as potential antineoplastic agents. Lin TS; Xu SP; Zhu LY; Cosby LA; Sartorelli AC J Med Chem; 1989 Jul; 32(7):1467-71. PubMed ID: 2738880 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumour activity of a new series of nitrosoureido sugars. Monneret C; Rissé S; Ardouin P; Gouyette A Eur J Med Chem; 2000 Jan; 35(1):137-46. PubMed ID: 10733610 [TBL] [Abstract][Full Text] [Related]
15. Rationale for the synthesis and preliminary biological evaluation of highly active new antitumor nitrosoureido sugars. Roger P; Monneret C; Fournier JP; Choay P; Gagnet R; Gosse C; Letourneux Y; Atassi G; Gouyette A J Med Chem; 1989 Jan; 32(1):16-23. PubMed ID: 2909727 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo anti-tumor activity of L-glutamic acid gamma-monohydroxamate against L1210 leukemia and B16 melanoma. Vila J; Thomasset N; Navarro C; Doré JF Int J Cancer; 1990 Apr; 45(4):737-43. PubMed ID: 2323850 [TBL] [Abstract][Full Text] [Related]